DataMeds AI, Inc. Increase (Decrease) in Accounts Payable
DataMeds AI, Inc. (MEDS) reported Increase (Decrease) in Accounts Payable of $2.43 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-17
- DataMeds AI, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $959.79K, a 24.14% decline year-over-year.
- DataMeds AI, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $1.47M, a 21.55% decline year-over-year.
- DataMeds AI, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$1.91M.
- DataMeds AI, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $960.05K.
- DataMeds AI, Inc. increase (decrease) in accounts payable for fiscal 2025 was $2.20M.
- DataMeds AI, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$882.32K, a 185.38% decline from fiscal 2023.
- DataMeds AI, Inc. increase (decrease) in accounts payable for fiscal 2023 was $1.03M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $959.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $2.43M 10-Q · filed 2026-08-17 | $525.91K derived: sum of 3 quarters · filed 2026-08-17 | $1.49M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $1.47M 10-Q · filed 2026-05-19 | -$433.88K derived: sum of 2 quarters · filed 2026-05-19 | $526.17K derived: sum of 3 quarters · filed 2026-05-19 | $1.79M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | -$1.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | -$946.08K derived: sum of 2 quarters · filed 2026-03-20 | $319.14K derived: sum of 3 quarters · filed 2026-08-17 | $2.20M 10-K · filed 2026-03-20 |
| 2025-09-30 | $960.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $2.23M derived: sum of 2 quarters · filed 2026-08-17 | $4.10M 10-Q · filed 2025-11-19 | $3.69M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $3.14M 10-Q · filed 2026-08-17 | $2.73M derived: sum of 3 quarters · filed 2026-08-17 | $2.46M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $1.88M 10-Q · filed 2026-05-19 | $1.47M derived: sum of 2 quarters · filed 2026-05-19 | $1.20M derived: sum of 3 quarters · filed 2026-05-19 | $912.72K derived: sum of 4 quarters · filed 2026-05-19 |
| 2024-12-31 | -$409.02K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | -$678.36K derived: sum of 2 quarters · filed 2026-03-20 | -$963.97K derived: sum of 3 quarters · filed 2026-03-20 | -$882.32K 10-K · filed 2026-03-20 |
| 2024-09-30 | -$269.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$554.94K derived: sum of 2 quarters · filed 2025-11-19 | -$473.29K 10-Q · filed 2025-11-19 | |
| 2024-06-30 | -$285.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | -$203.95K 10-Q · filed 2025-08-19 | ||
| 2024-03-31 | $81.65K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $1.03M 10-K · filed 2025-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |